ERBB2 and neoplasm: BRCA1-associated and basal-like breast tumours displayed greater transcriptome-wide variability compared to non-BRCA1 and non-basal-like (luminal A, luminal B, HER2 and normal-like) tumours (Fig. 1, Supplementary Fig. 1).